États-Unis · Places boursières & cours · Nasdaq

Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall

Publié par Nasdaq · États-Unis il y a 1 h

(RTTNews) - Biotechnology company Cerenome, Inc. (CNSY) announced on Wednesday that its CNSide Diagnostics unit has entered into a national in-network laboratory provider…

Lire l'article complet sur Nasdaq Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.nasdaq.com)

Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall

À lire aussi

Oil Crashes 9% as Trump and Vance Blame Iran War for Midterm Rout

Big Tech Rallies, Defense and Prison Stocks Sink: Here’s What’s Moving After the Democrats’ Sweep

Do you use AI agents to run your daily life? We want to hear about it

Stellar (XLM) Rises 3.6% Amid Crypto Market Rebound

Cboe FLEX Options Hit Record Volume in Q3 2026

New capabilities to power agents at scale with Google's Agentic Data Cloud

Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall

Partager

À lire aussi

Oil Crashes 9% as Trump and Vance Blame Iran War for Midterm Rout

Big Tech Rallies, Defense and Prison Stocks Sink: Here’s What’s Moving After the Democrats’ Sweep

Do you use AI agents to run your daily life? We want to hear about it

Stellar (XLM) Rises 3.6% Amid Crypto Market Rebound

Cboe FLEX Options Hit Record Volume in Q3 2026

New capabilities to power agents at scale with Google's Agentic Data Cloud